Home › Funds › Krensavage Asset Management, LLC › UTHR

Krensavage Asset Management, LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Krensavage Asset Management, LLC reported holding 69,282 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$37.5M, representing 14.26% of its reported portfolio and ranking #3 among its reported holdings. Krensavage Asset Management, LLC has disclosed UTHR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)69.28K sh
Reported value held$37.54M
Portfolio Weight14.26%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's UTHR position evolved

Krensavage Asset Management, LLC first disclosed a stake in UTHR in Q3 2023 at 201,222 shares (US$45.5M). The position peaked in Q1 2026 at 84,282 shares, worth US$50.0M. Across 12 filings, Krensavage Asset Management, LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 69,282 shares valued at US$37.5M — a reduction of -15,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 201.22K $45.45M New
Q4 2023 200.87K $44.17M Hold
Q1 2024 156.71K $36.00M Reduce
Q2 2024 118.21K $37.66M Reduce
Q3 2024 100.33K $35.95M Reduce
Q4 2024 92.06K $32.48M Reduce
Q1 2025 98.23K $30.28M Add
Q2 2025 101.15K $29.06M Add
Q3 2025 97.65K $40.93M Reduce
Q4 2025 91.28K $44.48M Reduce
Q1 2026 84.28K $49.98M Reduce
Q2 2026 69.28K $37.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Krensavage Asset Management, LLC held UTHR?

Krensavage Asset Management, LLC has disclosed UTHR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Krensavage Asset Management, LLC's current position in UTHR?

As of Q2 2026, Krensavage Asset Management, LLC holds 69.28K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $37.54M, representing 14.26% of its reported portfolio and ranking #3.

Has Krensavage Asset Management, LLC been buying or selling UTHR?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 84.28K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.